Safety, feasibility and trends of efficacy of intravenous injection of autologous adipose-derived mesenchymal stromal cells in patients with amyotrophic lateral sclerosis: A phase I-IIa multicenter randomized triple blind placebo controlled trial

被引：0
|
作者：
Lora, F. [1 ]
Fernandez, O. [3 ]
Aguera, E. [2 ]
Fernandez, V. E. [3 ]
Reyes, V. [3 ]
Navarro, G. [4 ]
Cabezas, J. A. [5 ]
Pena, M. A. [3 ]
Leyva, L. [6 ]
Macias, M. [1 ]
Garcia-Vinuesa, A. [1 ]
Mata, R. [1 ]
机构：
[1] Andalusian Network Design & Translat Adv Therapie, Seville, Spain
[2] Reina Sofia Hosp, Cordoba, Spain
[3] Reg Univ Hosp Malaga, Malaga, Spain
[4] Virgen Macarena Univ Hosp, Seville, Spain
[5] Virgen del Rocio Univ Hosp, Seville, Spain
[6] Reg Univ Hosp Malaga IBIMA, Cell Mfg Unit, GMP Network, Andalusian Initiat Adv Therapies, Malaga, Spain
来源：
HUMAN GENE THERAPY | 2019年 / 30卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P674
引用
收藏
页码：A212 / A212
页数：1
相关论文
共 50 条
  • [41] Intravenous transplantation of bone marrow-derived mesenchymal stromal cells in patients with multiple sclerosis, a phase I/II, double-blinded, randomized, controlled, crossed over clinical trial
    Nabavi, S. M.
    Karimi, S.
    Arab, L.
    Joghtaei, N.
    Maroufizadeh, S.
    Jarooghi, N.
    Bolurieh, T.
    Abbasi, F.
    Mardpour, S.
    Azimyian, V.
    Moeininia, F.
    Sanjari, L.
    Hosseini, S. E.
    Aghdami, N.
    Vosough, M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 914 - 915
  • [42] Safety and efficacy of intravenous injection of autologous bone marrow-derived mesenchymal stem cell in patients with multiple sclerosis: a double blind randomized semi-crossover clinical trial: preliminary report 1-safety issues
    Nabavi, S. M.
    Aghdami, N.
    Arab, L.
    Hamzeloo, A.
    JOURNAL OF NEUROLOGY, 2013, 260 : S130 - S131
  • [43] Ropinirole hydrochloride remedy for amyotrophic lateral sclerosis - Protocol for a randomized, double-blind, placebo-controlled, single-center, and open-label continuation phase I/IIa clinical trial (ROPALS trial)
    Morimoto, Satoru
    Takahashi, Shinichi
    Fukushima, Komei
    Saya, Hideyuki
    Suzuki, Norihiro
    Aoki, Masashi
    Okano, Hideyuki
    Nakahara, Jin
    REGENERATIVE THERAPY, 2019, 11 : 143 - 166
  • [44] Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: Results of a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial
    Shadmanfar, Soraya
    Labibzadeh, Narges
    Emadedin, Mohsen
    Jaroughi, Neda
    Azimian, Vajiheh
    Mardpour, Soura
    Kakroodi, Fatemeh Abbasi
    Bolurieh, Tina
    Hosseini, Seyyedeh Esmat
    Chehrazi, Mohammad
    Niknejadi, Maryam
    Baharvand, Hossein
    Gharibdoost, Farhad
    Aghdami, Nasser
    CYTOTHERAPY, 2018, 20 (04) : 499 - 506
  • [45] Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial
    Ludolph, Albert C.
    Schuster, Joachim
    Dorst, Johannes
    Dupuis, Luc
    Dreyhaupt, Jens
    Weishaupt, Jochen H.
    Kassubek, Jan
    Weiland, Ulrike
    Petri, Susanne
    Meyer, Thomas
    Grosskreutz, Julian
    Schrank, Berthold
    Boentert, Matthias
    Emmer, Alexander
    Hermann, Andreas
    Zeller, Daniel
    Prudlo, Johannes
    Winkler, Andrea S.
    Grehl, Torsten
    Heneka, Michael T.
    Johannesen, Siw Wollebaek
    Goericke, Bettina
    LANCET NEUROLOGY, 2018, 17 (08): : 681 - 688
  • [46] Intravenous transplantation of autologous bone marrow derived mesenchymal stromal cell (BM-MSCs) in patients with multiple sclerosis, a phase I/II, double blinded, randomized, cross clinical trial
    Nabavi, S. M.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 801 - 801
  • [47] Safety and efficacy of umbilical cord tissue-derived mesenchymal stem cells in the treatment of patients with aging frailty: a phase I/II randomized, double-blind, placebo-controlled study
    Zhu, Yingqian
    Huang, Ce
    Zheng, Liang
    Li, Qingqing
    Ge, Jianli
    Geng, ShaSha
    Zhai, Miaomiao
    Chen, Xin
    Yuan, Huixiao
    Li, Yang
    Jia, Wenwen
    Sun, Keping
    Li, Yan
    Ye, Tong
    Zhao, Zhengmei
    Liu, Hailiang
    Liu, Zhongmin
    Jiang, Hua
    STEM CELL RESEARCH & THERAPY, 2024, 15 (01) : 122
  • [48] CARDINALS: a phase 2, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of utreloxastat (PTC857) in patients with amyotrophic lateral sclerosis
    Katz, Jonathan S.
    Vu, Tuan
    Chio, Adriano
    McDermott, Chris
    Devos, David
    Gordon, Greg
    Johnston, Mayzie
    Maier, James
    Trimmer, Jeff
    Tansy, Aaron
    Shefner, Jeremy M.
    MUSCLE & NERVE, 2023, 68 : S61 - S62
  • [49] Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)
    Soria-Juan, Barbara
    Garcia-Arranz, Mariano
    Llanos Jimenez, Lucia
    Aparicio, Cesar
    Gonzalez, Alejandro
    Mahillo Fernandez, Ignacio
    Riera del Moral, Luis
    Grochowicz, Lukasz
    Andreu, Enrique J.
    Marin, Pedro
    Castellanos, Gregorio
    Moraleda, Jose Maria
    Garcia-Hernandez, Ana Maria
    Lozano, Francisco S.
    Sanchez-Guijo, Fermin
    Villaron, Eva Maria
    Parra, Miriam Lopez
    Yanez, Rosa Maria
    de la Cuesta Diaz, Antonio
    Tejedo, Juan Rigoberto
    Bedoya, Francisco J.
    Martin, Franz
    Miralles, Manuel
    del Rio Sola, Lourdes
    Fernandez-Santos, Maria Eugenia
    Ligero, Jose Manuel
    Morant, Francisco
    Hernandez-Blasco, Luis
    Andreu, Etelvina
    Hmadcha, Abdelkrim
    Garcia-Olmo, Damian
    Soria, Bernat
    TRIALS, 2021, 22 (01)
  • [50] Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)
    Barbara Soria-Juan
    Mariano Garcia-Arranz
    Lucía Llanos Jiménez
    César Aparicio
    Alejandro Gonzalez
    Ignacio Mahillo Fernandez
    Luis Riera del Moral
    Lukasz Grochowicz
    Enrique J. Andreu
    Pedro Marin
    Gregorio Castellanos
    Jose Maria Moraleda
    Ana Maria García-Hernández
    Francisco S. Lozano
    Fermin Sanchez-Guijo
    Eva María Villarón
    Miriam Lopez Parra
    Rosa María Yañez
    Antonio de la Cuesta Diaz
    Juan Rigoberto Tejedo
    Francisco J. Bedoya
    Franz Martin
    Manuel Miralles
    Lourdes del Rio Sola
    María Eugenia Fernández-Santos
    José Manuel Ligero
    Francisco Morant
    Luis Hernández-Blasco
    Etelvina Andreu
    Abdelkrim Hmadcha
    Damian Garcia-Olmo
    Bernat Soria
    Trials, 22
12345